Franklin Resources
AUPH icon

Franklin Resources’s Aurinia Pharmaceuticals AUPH Stock Holding History

Franklin Resources’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Sell
126,402
-6,105
-5% -$97.5K ﹤0.01% 1970
2026
Q1 		$1.96M Sell
132,507
-56
-0% -$819 ﹤0.01% 1918
2025
Q4 		$2.11M Buy
132,563
+5,057
+4% +$71.7K ﹤0.01% 1755
2025
Q3 		$1.41M Buy
127,506
+18,047
+16% +$197K ﹤0.01% 1930
2025
Q2 		$927K Buy
109,459
+16,538
+18% +$133K ﹤0.01% 2024
2025
Q1 		$747K Hold
92,921
– – ﹤0.01% 2095
2024
Q4 		$834K Buy
92,921
+72,668
+359% +$593K ﹤0.01% 2057
2024
Q3 		$144K Sell
20,253
-75,024
-79% -$465K ﹤0.01% 2702
2024
Q2 		$544K Buy
95,277
+12,257
+15% +$64.6K ﹤0.01% 2191
2024
Q1 		$416K Sell
83,020
-97
-0.1% -$658 ﹤0.01% 2334
2023
Q4 		$747K Sell
83,117
-4,031
-5% -$33.2K ﹤0.01% 1769
2023
Q3 		$677K Sell
87,148
-1,116
-1% -$10.9K ﹤0.01% 1768
2023
Q2 		$854K Buy
+88,264
New +$916K ﹤0.01% 1703
2021
Q1 		– Sell
-38,800
Closed -$535K – 1980
2020
Q4 		$535K Buy
38,800
+13,300
+52% +$194K ﹤0.01% 1533
2020
Q3 		$375K Sell
25,500
-1,133,100
-98% -$16.4M ﹤0.01% 1535
2020
Q2 		$19.3M Sell
1,158,600
-101,000
-8% -$1.62M 0.01% 744
2020
Q1 		$18.3M Sell
1,259,600
-68,400
-5% -$1.21M 0.01% 691
2019
Q4 		$26.9M Sell
1,328,000
-79,500
-6% -$732K 0.01% 697
2019
Q3 		$7.52M Hold
1,407,500
– – ﹤0.01% 925
2019
Q2 		$9.26M Sell
1,407,500
-205,400
-13% -$1.31M ﹤0.01% 907
2019
Q1 		$10.5M Sell
1,612,900
-225,600
-12% -$1.5M 0.01% 861
2018
Q4 		$12.5M Hold
1,838,500
– – 0.01% 831
2018
Q3 		$12.2M Buy
1,838,500
+105,300
+6% +$591K 0.01% 895
2018
Q2 		$9.76M Buy
1,733,200
+68,800
+4% +$384K 0.01% 924
2018
Q1 		$8.64M Hold
1,664,400
– – ﹤0.01% 947
2017
Q4 		$7.54M Buy
1,664,400
+414,400
+33% +$2.3M ﹤0.01% 997
2017
Q3 		$7.84M Hold
1,250,000
– – ﹤0.01% 1002
2017
Q2 		$7.66M Hold
1,250,000
– – ﹤0.01% 1014
2017
Q1 		$9.18M Buy
+1,250,000
New +$5.77M ﹤0.01% 983

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's AUPH Position: Q2 2026 in Review

Franklin Resources reduced its Aurinia Pharmaceuticals (AUPH) stake by 4.6% in Q2 2026, selling an estimated $97.5K and leaving 126,402 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Franklin Resources first reported a position in AUPH in Q1 2017 and has held it in 29 quarters since. The position peaked at $26.9M in Q4 2019. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Franklin Resources held 126,402 shares of Aurinia Pharmaceuticals worth $2.15M as of Q2 2026.
  • Franklin Resources sold 6,105 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $97.5K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1970 holding.
  • Franklin Resources first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 29 quarters since.
  • Franklin Resources's Aurinia Pharmaceuticals position peaked at $26.9M in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.